Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
32.14
2.07 (6.88%)
At close: May 12, 2025, 3:59 PM
32.41
0.84%
Pre-market: May 13, 2025, 05:35 AM EDT

Kymera Therapeutics Revenue

Kymera Therapeutics reported an annual revenue of $47.07M, reflecting a -40.11% growth. For the quarter ending December 31, 2024, Kymera Therapeutics generated $7.39M in revenue.
Revenue (ttm)
$47.07M
Revenue Growth
-40.11%
Price / Sales Ratio
64.14
Revenue / Employee
$226.31K
Employees
208
Market Cap
2.09B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.